lorcainide

This page covers all lorcainide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium channel subunit beta-1, Sodium channel subunit beta-2, Sodium channel subunit beta-3.

Targets

Sodium channel subunit beta-1, Sodium channel subunit beta-2, Sodium channel subunit beta-3

Phase 2 pipeline (1)

• Lorcamide · Cardiovascular
  Lorcainide works by blocking sodium channels in the heart to regulate abnormal heart rhythms.

Patent intelligence

• lorcainide patent landscape — aggregated cliff calendar, attackable patents, originator estates